Pharmacogenetics of the major polymorphic metabolizing enzymes.
about
Applications of CYP450 testing in the clinical settingInvestigation by site-directed mutagenesis of the role of cytochrome P450 2B4 non-active-site residues in protein-ligand interactions based on crystal structures of the ligand-bound enzymeDevelopment and progress for three decades in umu test systemsIdentification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Pharmacogenomics and drug response in cardiovascular disordersMaternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis riskSimultaneous genotyping of GSTT1 and GSTM1 null polymorphisms by melting curve analysis in presence of SYBR Green I.Maternal-fetal and neonatal pharmacogenomics: a review of current literature.Pharmacogenetics in drug regulation: promise, potential and pitfalls.Pharmacogenetics in drug development.Human pharmacogenomic variations and their implications for antifungal efficacy.Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCXGenetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm.Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.The role of genetic variability in drug metabolism pathways in breast cancer prognosis.Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: The convolution continues.Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.Role of the aryl hydrocarbon receptor in drug metabolism.Phase I and Phase II enzyme polymorphisms and childhood cancer.Candidate genes for antidepressant response to selective serotonin reuptake inhibitorsAssociation of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifenDefining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy.PhRMA white paper on ADME pharmacogenomics.Clinical utility of microarrays: current status, existing challenges and future outlook.Introducing pharmacy students to pharmacogenomic analysisGlobal variation in CYP2C8-CYP2C9 functional haplotypesCharacterisation of the metabolites of 1,8-cineole transferred into human milk: concentrations and ratio of enantiomers.Pharmacokinetics in special populations.Pharmacogenetics and human genetic polymorphisms.Multi-step oxidations catalyzed by cytochrome P450 enzymes: Processive vs. distributive kinetics and the issue of carbonyl oxidation in chemical mechanisms.Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics.Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.Gene-environment interactions in esophageal cancer.Alternative Sampling Strategies for Cytochrome P450 Phenotyping.Advanced Approaches to Model Xenobiotic Metabolism in Bacterial Genotoxicology In Vitro.NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.
P2860
Q24621760-4E73EB52-8282-4BCA-98AD-D21C45667DCDQ27675363-D40CB83B-194B-4F16-A67F-9B70BCC338E3Q28075300-C2DDA159-6748-404A-967F-D30DCE7038D0Q28080914-54161501-A146-474A-8359-D1CF32A58BB1Q28171051-CFC8569C-2382-4C49-A3B3-E210D8A4459BQ28391030-EA5A14E1-6CC6-499E-897D-D6AE890AE3FEQ33813842-B5E22BAD-8716-49BB-9862-93793758D20DQ34994866-A13738B9-DCB9-444B-A0C0-F2D1F46F7125Q35038052-C3A47EE8-DA69-472C-BE9D-74242D416FA2Q35038056-BD36A3C0-6F4E-483A-9ACA-6B603EF8EE40Q35070838-6DAD9EE3-A0BF-4153-8F42-08045128708FQ35706472-E8AFFE63-F7A0-43C4-8A5B-2346823EA999Q35812542-F3375A01-3F28-4BDA-98EB-0794278A28A7Q35826495-59BBE78C-024E-456A-BB2C-28FE7A1C48E9Q36028625-298BAA4C-59F5-4EDD-AA88-6897200A9C81Q36497088-A9798A1F-1DF8-4D22-A3E8-16631302DCD1Q36544917-6E944571-F69A-42F7-87BA-F37935C01FF5Q36555922-F199724D-CBC5-4740-B1A7-1DACE4A65029Q36572621-3720A8D1-8724-43AC-98AC-27230C94C293Q36668333-AA4D1A9D-DFEA-454B-B46F-C42E5C74F368Q36718053-84CB3053-46B2-40E4-B80C-E1D1A5C764F0Q36925964-E5D89489-A456-495A-9C0D-F4BD6772C7B6Q37157893-D86D54C9-8882-4D4B-8511-CD9C0BDF6859Q37176949-02CBDDBF-3C7B-4D0D-8BA8-1E37375DC58EQ37182212-B6A4B3D7-325D-4DAF-9CB9-16B61D8BAB7CQ37214951-1BA0FD86-7B1E-4B04-B669-5CAE3BD84530Q37287902-842FFA89-0579-480E-942D-8FB60E94267EQ37434738-9FA6E489-B82B-4E17-B653-725B574EF909Q37512718-FA61CDDE-BF2F-4269-A9BA-ABBC3044C188Q37550561-3D8EF82F-EBF9-4767-8492-9DCA79D11532Q37772183-A4B40AD3-D0C2-4668-9EE2-5A7763BC4DB9Q37784053-273CC4B1-B467-4816-BD56-A3A31996BACDQ37904672-81A6C895-462F-4317-BEBC-5AAA29BA55BFQ37964573-AF1EAB5A-76CA-4A1F-96AA-22D16B1155A3Q37964574-0B2E5F27-FEDF-4A6F-9041-7E9CBD5813BBQ38048826-FD4F0892-9CAD-4CD0-9C33-A954FC3D32D2Q38556530-0C414C5D-4990-4CDD-8860-F611B0B1D55DQ38560254-49E60092-9E80-4246-9DA9-AAF37EE77506Q38822086-61CDA08D-DF96-4383-A816-E54D1429E9DBQ38842411-79EF35F3-0D9F-4456-BB36-55F82277C7E9
P2860
Pharmacogenetics of the major polymorphic metabolizing enzymes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Pharmacogenetics of the major polymorphic metabolizing enzymes.
@ast
Pharmacogenetics of the major polymorphic metabolizing enzymes.
@en
type
label
Pharmacogenetics of the major polymorphic metabolizing enzymes.
@ast
Pharmacogenetics of the major polymorphic metabolizing enzymes.
@en
prefLabel
Pharmacogenetics of the major polymorphic metabolizing enzymes.
@ast
Pharmacogenetics of the major polymorphic metabolizing enzymes.
@en
P2860
P1476
Pharmacogenetics of the major polymorphic metabolizing enzymes
@en
P2093
P2860
P356
10.1046/J.1472-8206.2003.00119.X
P50
P577
2003-02-01T00:00:00Z